In vivo footprinting analysis of the human kinin B1 receptor gene promoter

2000 ◽  
Vol 28 (5) ◽  
pp. A264-A264
Author(s):  
D. Bachvarov ◽  
M. Angers ◽  
M. Bachvarova ◽  
I. Paradis ◽  
F. Marceau ◽  
...  
1988 ◽  
Vol 8 (10) ◽  
pp. 4174-4184
Author(s):  
A C Johnson ◽  
Y Jinno ◽  
G T Merlino

The epidermal growth factor (EGF) receptor is the functional target of the mitogen EGF and the cellular homolog of the avian erythroblastosis virus erbB oncogene product. Regulation of expression of the proto-oncogene encoding the EGF receptor can be elucidated by studying the structure and function of the gene promoter outside the confines of the cell. Previously, we reported the isolation of the human EGF receptor gene promoter. The promoter is highly GC rich, contains no TATA or CAAT box, and has multiple transcription start sites. An S1 nuclease-sensitive site has now been found 80 to 110 base pairs (bp) upstream from the major in vivo transcription initiation site. Two sets of direct repeat sequences were found in this area; both conform to the motif TCCTCCTCC. When deletion mutations were made in this region of the promoter by using either Bal 31 exonuclease or S1 nuclease, we found that in vivo activity dropped three- to fivefold, on the basis of transient-transfection analysis. Examination of nuclear protein binding to normal and mutated promoter DNAs by gel retardation analysis and DNase I footprinting revealed that two specific factors bind to the direct repeat region but cannot bind to the S1 nuclease-mutated promoter. One of the specific factors is the transcription factor Sp1. The results suggest that these nuclear trans-acting factors interact with the S1 nuclease-sensitive region of the EGF receptor gene promoter and either directly or indirectly stimulate transcription.


Peptides ◽  
2009 ◽  
Vol 30 (5) ◽  
pp. 901-905 ◽  
Author(s):  
Ana M.R.B. Barbosa ◽  
Sandra A. Felipe ◽  
Ronaldo C. Araujo ◽  
Elisa M. Kawamoto ◽  
Maria H.C. Carvalho ◽  
...  

2004 ◽  
Vol 20 (2) ◽  
pp. 363-374 ◽  
Author(s):  
Mark Ansorge ◽  
Cornelia Tanneberger ◽  
Benjamin Davies ◽  
Franz Theuring ◽  
Heike Kusserow
Keyword(s):  

2005 ◽  
Vol 389 (1) ◽  
pp. 37-46 ◽  
Author(s):  
Martin ANGERS ◽  
Régen DROUIN ◽  
Magdalena BACHVAROVA ◽  
Isabelle PARADIS ◽  
Brad BISSELL ◽  
...  

By applying in vivo dimethyl sulphate and UV light type C-footprinting analysis, we previously showed that specific DNA sequences in the −1349/+42 core promoter region of the inducible human BDKRB1 (bradykinin B1 receptor) gene correlated with its transcriptional activity. In the present study we used the highly sensitive DNase I in vivo footprinting approach to delineate more precisely the functional domains of the BDKRB1 gene promoter in human SMCs (smooth muscle cells). Human lymphocytes that do not express a functional BDKRB1 were also studied as a reference using dimethyl sulphate, UV light type C and DNase I treatments. An obvious difference was found in the DNase I-footprinting patterns between cellular systems that express a functional BDKRB1 (SMCs) in comparison with human lymphocytes, where randomly distributed nucleosome-like footprinting patterns were found in the bulk of the core promoter region studied. Gel-shift assays and expression studies pointed to the implication of the YY1 and a TBP/TFIIB (TATA-box-binding protein/transcription factor IIB) transcription factor in the regulation of BDKRB1 gene expression in SMCs and possible YY1 involvement in the mechanisms of nuclear factor κB-mediated regulation of the receptor expression. No significant changes in the promoter foot-printing pattern were found after treatment with interleukin-1β or serum (known BDKRB1 gene inducers), indicating that definite regulatory motifs could exist outside the BDKRB1 gene core promoter region studied.


2007 ◽  
Vol 56 (S3) ◽  
pp. S488-S491
Author(s):  
Elizabeth S. Fernandes ◽  
Rodrigo Medeiros ◽  
Maria M. Campos ◽  
Joao B. Calixto

1999 ◽  
Vol 80 (1-2) ◽  
pp. 41-47 ◽  
Author(s):  
Alessandro Lecci ◽  
Stefania Meini ◽  
Manuela Tramontana ◽  
Sandro Giuliani ◽  
Marco Criscuoli ◽  
...  

2008 ◽  
Vol 389 (6) ◽  
Author(s):  
Dirk Westermann ◽  
Olga Lettau ◽  
Meike Sobirey ◽  
Alexander Riad ◽  
Michael Bader ◽  
...  

Abstract Clinical use of the anthracycline doxorubicin (DOX) is limited by its cardiotoxic effects, which are attributed to the induction of apoptosis. To elucidate the possible role of the kinin B1 receptor (B1R) during the development of DOX cardiomyopathy, we studied B1R knockout mice (B1R-/-) by investigating cardiac inflammation and apoptosis after induction of DOX-induced cardiomyopathy. DOX control mice showed cardiac dysfunction measured by pressure-volume loops in vivo. This was associated with a reduced activation state of AKT, as well as an increased bax/bcl2 ratio in Western blots, indicating cardiac apoptosis. Furthermore, mRNA levels of the proinflammatory cytokine interleukin 6 were increased in the cardiac tissue. In DOX B1R-/- mice, cardiac dysfunction was improved compared to DOX control mice, which was associated with normalization of the bax/bcl-2 ratio and interleukin 6, as well as AKT activation state. These findings suggest that B1R is detrimental in DOX cardiomyopathy in that it mediates the inflammatory response and apoptosis. These insights might have useful implications for future studies utilizing B1R antagonists for treatment of human DOX cardiomyopathy.


2013 ◽  
Vol 394 (7) ◽  
pp. 901-908 ◽  
Author(s):  
Hugo A.M. Torres ◽  
Fabiana Louise Motta ◽  
Vicencia Micheline Sales ◽  
Carolina Batista ◽  
Joelcimar M. da Silva ◽  
...  

Abstract A role for the kinin B1 receptor in energy-homeostatic processes was implicated in previous studies; notably, the studies where kinin B1 receptor knockout mice (B1-/-) were shown to have impaired adiposity, impaired leptin and insulin production, lower feed efficiency, protection from liver steatosis and diet-induced obesity when fed a high fat diet (HFD). In particular, in a model where the B1 receptor is expressed exclusively in the adipose tissue, it rescues the plasma insulin concentration and the weight gain seen in wild type mice. Taking into consideration that leptin participates in the formation of hypothalamic nuclei, which modulate energy expenditure, and feeding behavior, we hypothesized that these brain regions could also be altered in B1-/- mice. We observed for the first time a difference in the gene expression pattern of cocaine and amphetamine related transcript (CART) in the (lateral hypothalamic area (LHA) resulting from the deletion of the kinin B1 receptor gene. The correlation between CART expression in the LHA and the thwarting of diet-induced obesity corroborates independent correlations between CART and obesity. Furthermore, it seems to indicate that the mechanism underlying the ‘lean’ phenotype of B1-/- mice does not stem solely from changes in peripheral tissues but may also receive contributions from changes in the hypothalamic machinery involved in energy homeostasis processes.


Sign in / Sign up

Export Citation Format

Share Document